Simcere

HealthcareSeries BNanjing, China

Latest round

Series B

Last raised

Jun 2021

Total raised

$94M

Investors

13

About Simcere

, trading as Simcere, is a precision medical solution provider under Sincere Pharmaceutical Group Limited, providing medical diagnostic products and services. The company's main product is a SDx MassARRAY MALDI-TOF mass spectrometric detection system based on matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS), which can be applied to tumor detection, pharmacogenomics detection, infectious disease detection and genetic disease detection, etc. Besides, the company also operates as a personal testing platform, YOAI MEDICINE, providing services such as cervical cancer screening, vaginitis testing, and venereal disease testing. The company generates revenue by providing precision medicine solutions for healthcare professionals in the fields of oncology, central nervous system, infectious diseases, pharmacogenomic, and autoimmune diseases.

Who invested in Simcere

13 investors across 2 rounds

See all investors in Simcere

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jun 3, 2021

    Amount

    $94M

    Investors

    Locked

  2. Series A

    Oct 13, 2020

    Amount

    Undisclosed

    Investors

    Locked

Questions about Simcere

Who invested in Simcere?

Simcere has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Simcere raised?

Simcere has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Simcere last raise money?

Simcere's most recent round on record is a Series B, in Jun 2021.

What does Simcere do?

, trading as Simcere, is a precision medical solution provider under Sincere Pharmaceutical Group Limited, providing medical diagnostic products and services.

Where is Simcere headquartered?

Simcere is headquartered in Nanjing, China.

Which VCs invest in companies like Simcere?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Hengxu Capital and Riverhead Capital back healthcare companies at Simcere's stage. Their profiles are linked below.

Raising like Simcere? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.